|
IL248148B
(en)
|
2016-09-29 |
2021-09-30 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
A method for extracting a compound from plant origin
|
|
IL248150B
(en)
|
2016-09-29 |
2018-05-31 |
Garti Nissim |
Method for selective extraction of cannabinoids from a plant source
|
|
IL248149B
(en)
|
2016-09-29 |
2020-03-31 |
Garti Nissim |
Dilutable formulations of cannbinoids and processes for their preparation
|
|
US10239808B1
(en)
|
2016-12-07 |
2019-03-26 |
Canopy Holdings, LLC |
Cannabis extracts
|
|
EP3582755A4
(en)
*
|
2017-02-15 |
2020-12-23 |
Molecular Infusions, LLC |
PREPARATIONS
|
|
DK3651804T5
(da)
*
|
2017-07-11 |
2023-10-09 |
Aquanova Ag |
Solubilisat med curcumin, boswellia og xanthohumol
|
|
US20190151280A1
(en)
*
|
2017-11-17 |
2019-05-23 |
Tilray, Inc. |
Cannabinoid Compositions
|
|
CA3089994A1
(en)
|
2018-01-31 |
2019-08-08 |
Canopy Holdings, LLC |
Hemp powder
|
|
WO2019153073A1
(en)
|
2018-02-07 |
2019-08-15 |
Scf Pharma Inc. |
Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
|
|
CA3092914A1
(en)
*
|
2018-03-05 |
2019-09-12 |
Solva, Llc |
Water-soluble phytocannabinoid formulations
|
|
AU2019251357B2
(en)
*
|
2018-04-09 |
2023-10-05 |
Portland Technology Holdings Llc |
Hemp extract for treatment of pain in animals
|
|
CA3054203C
(en)
|
2018-05-03 |
2021-01-05 |
Scf Pharma Inc. |
Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
|
|
HRP20231263T1
(hr)
*
|
2018-07-11 |
2024-02-02 |
Aquanova Ag |
Solubilizat koji sadrži kurkumin i barem jedan kanabinoid kao dodatnu aktivnu tvar
|
|
PL3820527T3
(pl)
|
2018-07-11 |
2024-01-03 |
Aquanova Ag |
Solubilizator ksantohumolu
|
|
WO2020021543A1
(en)
*
|
2018-07-25 |
2020-01-30 |
Bol Pharma Ltd. |
Cannabidiol and curcumin for treating inflammatory diseases
|
|
MX2021002050A
(es)
*
|
2018-08-20 |
2021-07-15 |
Hexo Operations Inc |
Producto infundido con cannabis con experiencia de usuario de perfil de cannabinoides potenciado.
|
|
US20210196670A1
(en)
*
|
2018-08-27 |
2021-07-01 |
Emerald Health Therapeutics Canada Inc. |
Oral formulations of lavender and cannabinoids
|
|
US10828254B2
(en)
|
2018-09-28 |
2020-11-10 |
Intelgenx Corp. |
Oral film formulation for modulating absorption profile
|
|
WO2020077153A1
(en)
|
2018-10-10 |
2020-04-16 |
Canopy Holdings, LLC |
Synthesis of cannabigerol
|
|
US11602504B2
(en)
*
|
2018-11-05 |
2023-03-14 |
Intelgenx Corp. |
Lipophilic active oral film formulation and method of making the same
|
|
US12303501B2
(en)
|
2018-11-05 |
2025-05-20 |
Intelgenx Corp. |
Lipophilic active oral film formulation and method of making the same
|
|
US20220000763A1
(en)
*
|
2018-11-07 |
2022-01-06 |
Columbia Care Llc |
Sublingual and buccal dosage forms of cannabinoid extracts and method of use thereof
|
|
GB2579179A
(en)
*
|
2018-11-21 |
2020-06-17 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
CA3128712A1
(en)
*
|
2018-11-30 |
2020-06-04 |
Canopy Growth Corporation |
Water-soluble formulations of cannabinoids or cannabis-derived compounds, methods of making and use
|
|
CN117695226A
(zh)
|
2018-12-11 |
2024-03-15 |
迪斯拉普申实验室公司 |
用于递送治疗剂的组合物及其使用方法和制备方法
|
|
US20200188301A1
(en)
|
2018-12-14 |
2020-06-18 |
NuVessl, Inc. |
Method for Enhancing Passenger Molecule Loading
|
|
CA3124445A1
(en)
*
|
2018-12-19 |
2020-06-25 |
Tilray, Inc. |
Cannabinoid formulations and pharmaceutical compositions
|
|
BR102018076973A2
(pt)
*
|
2018-12-21 |
2020-09-15 |
Entourage Participações S.A. |
Composição farmacêutica compreendendo extrato de cannabis, produto farmacêutico, processo de preparação da dita composição
|
|
US11026888B1
(en)
|
2019-01-04 |
2021-06-08 |
Nutrition Therapeutics, Inc. |
Functional beverage compositions and methods of using and making same
|
|
CA3038349C
(en)
|
2019-01-31 |
2021-04-13 |
Nam Hai LAI |
Process for producing a nano-cbd liposome system
|
|
CA3040532C
(en)
*
|
2019-04-17 |
2021-12-21 |
Medcan Pharma A/S |
Lozenge for improved delivery of cannabinoids
|
|
CA3137225A1
(en)
|
2019-04-18 |
2020-10-22 |
Simon Benita |
Self-emulsifying drug delivery systems for delivery of lipophilic compounds
|
|
KR20220080045A
(ko)
*
|
2019-04-24 |
2022-06-14 |
인메드 파마슈티컬스 인코포레이티드 |
신경보호를 위한 칸나비노이드의 사용을 위한 조성물 및 방법
|
|
KR102205207B1
(ko)
*
|
2019-04-26 |
2021-01-20 |
주식회사 그린러쉬 농업회사법인 |
대마씨앗 추출물을 함유하는 음료 조성물
|
|
US20200360292A1
(en)
*
|
2019-05-16 |
2020-11-19 |
Aegis Therapeutics, Llc |
Oil-soluble drug containing compositions and methods of use thereof
|
|
LU102486B1
(en)
*
|
2019-06-03 |
2021-06-15 |
Fresh Cut Dev Llc |
Cannabidiol nanocrystal compositions
|
|
GB201910389D0
(en)
|
2019-07-19 |
2019-09-04 |
Gw Pharma Ltd |
Novel compounds, methods for their manufacture, and uses thereof
|
|
US12226390B2
(en)
|
2019-07-21 |
2025-02-18 |
Scf Pharma Inc. |
Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
|
|
CA3148277A1
(en)
*
|
2019-07-22 |
2021-01-28 |
Canopy Growth Corporation |
Continuous crystallization of cannabinoids in a tubular flow reactor
|
|
AU2020326738A1
(en)
*
|
2019-08-08 |
2022-03-03 |
Purcann Pharma Inc. |
Oral formulations of cannabis extracts and methods of making same
|
|
CN114302732A
(zh)
*
|
2019-08-09 |
2022-04-08 |
西梯茜科学公司 |
包含大麻油提取物或粉末提取物作为制剂的原料的口腔内速崩制剂
|
|
EP4009954A4
(en)
*
|
2019-08-10 |
2023-07-26 |
Locus IP Company, LLC |
METHOD OF INCREASING THE BIOAVAILABILITY OF OTC AND PHARMACEUTICAL DRUGS
|
|
EP4013397A1
(en)
*
|
2019-08-13 |
2022-06-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Phytocannabinoids for preventing or treating non-alcoholic fatty liver disease, dyslipidemia, and type 2 diabetes
|
|
WO2021034403A1
(en)
*
|
2019-08-22 |
2021-02-25 |
Epm Group, Inc. |
Cannabinoid acid ester compositions and uses thereof
|
|
EP3782607A1
(en)
*
|
2019-08-23 |
2021-02-24 |
NuVessl Inc. |
Composition with enhanced passenger molecule loading
|
|
CN115135596B
(zh)
*
|
2019-09-06 |
2025-03-21 |
快饮科学公司 |
包括非衍生化激素在内的醇溶性物质的微乳液递送体系
|
|
EP4025198A4
(en)
*
|
2019-09-06 |
2023-09-13 |
Quicksilver Scientific, Inc. |
MICROEMULSION DELIVERY SYSTEMS FOR CANNABIS EXTRACTS AND TERPENES
|
|
WO2021046189A1
(en)
|
2019-09-06 |
2021-03-11 |
Quicksilver Scientific, Inc. |
Microemulsion delivery systems for water-based beverages
|
|
WO2021055777A1
(en)
*
|
2019-09-20 |
2021-03-25 |
Mycotechnology, Inc. |
Methods for reduction of bitterness in cannabinoids using mycelial materials
|
|
US11542243B1
(en)
|
2019-09-26 |
2023-01-03 |
FusionFarms, LLC |
Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
|
|
JP2022551476A
(ja)
*
|
2019-10-08 |
2022-12-09 |
ベッソール ファルマ、エルエルシー |
カンナビノイド及びカンナビノイド酸の製造プロセス
|
|
US20220401380A1
(en)
*
|
2019-10-25 |
2022-12-22 |
Cardiol Therapeutics Inc. |
Cannabidiol compositions for use in treating heart conditions
|
|
US20220370531A1
(en)
*
|
2019-11-04 |
2022-11-24 |
Landrace Bioscience Inc. |
Self-emulsifying cannabinoid formulation and method
|
|
CN110638756B
(zh)
*
|
2019-11-07 |
2021-10-08 |
辰风天然本草(北京)科技有限公司 |
一种含大麻二酚的组合物及其制备方法
|
|
GB201916849D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916846D0
(en)
|
2019-11-19 |
2020-01-01 |
Gw Res Ltd |
Cannabidiol-type cannabinoid compound
|
|
GB201916974D0
(en)
|
2019-11-21 |
2020-01-08 |
Gw Res Ltd |
Cannabidol-type cannabinoid compound
|
|
CN112915121A
(zh)
*
|
2019-12-06 |
2021-06-08 |
汉义生物科技（北京）有限公司 |
一种大麻素纳米胶束制剂及其制备方法
|
|
JP2023504756A
(ja)
|
2019-12-09 |
2023-02-06 |
ニコベンチャーズ トレーディング リミテッド |
カンナビノイドを含む口腔用製品
|
|
WO2021119844A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Organigram Inc. |
Emulsifying formulations of cannabinoids and/or cannabinoid extracts
|
|
UY39010A
(es)
*
|
2020-01-10 |
2021-08-31 |
Monsanto Technology Llc |
Composiciones de herbicidas de auxina que incluyen agentes retardantes de la deriva y métodos de preparacion de las mismas
|
|
CN113117092A
(zh)
*
|
2020-01-14 |
2021-07-16 |
中国科学院上海药物研究所 |
一种非水缓释递药系统
|
|
US11590187B2
(en)
*
|
2020-01-14 |
2023-02-28 |
Shaman Naturals, Llc |
Antimicrobial compositions
|
|
EP3871510A1
(en)
*
|
2020-02-25 |
2021-09-01 |
Tapperwein Collection AG |
Medium chain triglyceride based oil phase in water microemulsions
|
|
US20220401378A1
(en)
*
|
2020-03-09 |
2022-12-22 |
This Works Products Limited |
Compositions comprising functional fragrances and cannabis-derived compounds
|
|
US20230049319A1
(en)
*
|
2020-05-04 |
2023-02-16 |
This Works Products Limited |
Cannabinoid-comprising cosmetic compositions
|
|
WO2022011460A1
(en)
*
|
2020-07-13 |
2022-01-20 |
Hexo Operations Inc. |
Transmucosal cannabis compositions with enhanced permeation properties
|
|
GB2597321A
(en)
|
2020-07-20 |
2022-01-26 |
Gw Res Ltd |
Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to genetic abnormalities
|
|
US12029718B2
(en)
|
2021-11-09 |
2024-07-09 |
Cct Sciences, Llc |
Process for production of essentially pure delta-9-tetrahydrocannabinol
|
|
WO2022091061A1
(en)
*
|
2020-11-01 |
2022-05-05 |
Ai Pharmaceuticals Jamaica Limited |
Cannabis compositions and nanoemulsions
|
|
CN114515258B
(zh)
*
|
2020-11-20 |
2022-11-18 |
中国海洋大学 |
苯乙基间苯二酚纳米结构脂质载体、制备方法及在化妆品中的应用
|
|
US11839602B2
(en)
|
2020-11-25 |
2023-12-12 |
Nicoventures Trading Limited |
Oral cannabinoid product with lipid component
|
|
GB2602019A
(en)
|
2020-12-15 |
2022-06-22 |
Gw Res Ltd |
Cannabinoid derivative as a pharmaceutically active compound and method of preparation thereof
|
|
AU2020481908A1
(en)
*
|
2020-12-16 |
2023-06-29 |
TARK, Hye Ryun |
Method for preparing vegetable oil emulsion using cannabidiol oil
|
|
JP2024500187A
(ja)
*
|
2020-12-21 |
2024-01-04 |
アイソセレス ファーマシューティカルズ，インコーポレイテッド |
非経口カンナビノイド配合物およびその使用
|
|
CN112716897A
(zh)
*
|
2021-02-07 |
2021-04-30 |
澳门德诚生物科技有限公司 |
一种含纳米级大麻二酚的高度酒精饮料及其制备方法
|
|
CA3217137A1
(en)
|
2021-04-29 |
2022-11-03 |
Christopher Adair |
Cannabidiol-dominant formulations, methods of manufacturing, and uses thereof
|
|
DK181329B1
(en)
|
2021-05-04 |
2023-08-16 |
Cs Medica As |
Nasal sleep spray composition, method for its provision, and receptacle and kit comprising said composition
|
|
IL308880A
(en)
|
2021-05-28 |
2024-01-01 |
Ananda Scient Inc |
Methods for the treatment of post-traumatic stress disorder and traumatic brain injury with cannabinoids
|
|
JP2023010676A
(ja)
*
|
2021-07-09 |
2023-01-20 |
株式会社東洋新薬 |
固形組成物
|
|
WO2023287891A1
(en)
*
|
2021-07-13 |
2023-01-19 |
Demetrix, Inc. |
Compositions and methods using cannabinoid compounds for regulating gastric acid secretion to treat gastroesophageal reflux disease and related conditions
|
|
JP2024528844A
(ja)
*
|
2021-07-22 |
2024-08-01 |
ニコベンチャーズ トレーディング リミテッド |
カンナビスの成分、誘導体又は抽出物を含む組成物
|
|
US20240335415A1
(en)
*
|
2021-07-22 |
2024-10-10 |
Nicoventures Trading Limited |
Compositions comprising constituents, derivatives or extracts of cannabis
|
|
JP2023020034A
(ja)
*
|
2021-07-30 |
2023-02-09 |
株式会社東洋新薬 |
皮膚外用剤
|
|
WO2023072954A1
(en)
*
|
2021-10-25 |
2023-05-04 |
Lipidor Ab |
Topical cannabinoid compositions
|
|
US12527804B2
(en)
|
2021-10-27 |
2026-01-20 |
Quicksilver Scientific, Inc. |
Microemulsion delivery systems for alcohol-soluble species including DHEA, pregnenolone, and chrysin for reducing menopausal symptoms
|
|
WO2023129153A1
(en)
*
|
2021-12-29 |
2023-07-06 |
Pegasus Laboratories, Inc. |
Granular composition providing water dispersible cannabinoids and methods of making the same
|
|
US12440454B2
(en)
|
2022-02-01 |
2025-10-14 |
Portland Technology Holdings Llc |
Pharmaceutical compositions containing hemp extract for administration to felines and related methods
|
|
EP4518971A4
(en)
*
|
2022-05-05 |
2026-04-29 |
Ananda Scient Inc |
SYSTEM AND METHOD FOR MANAGING RELATIONSHIPS, ORGANIZING, RETRIEVING AND SHARING DIFFERENT TYPES OF CONTENT
|
|
KR20250089549A
(ko)
|
2022-11-01 |
2025-06-18 |
에이커 바이오마린 휴먼 인그리디언트 에이에스 |
치료 화합물의 전달을 위한 인지질 조성물
|
|
KR20240150100A
(ko)
|
2023-04-07 |
2024-10-15 |
주식회사 네오켄바이오 |
칸나비오르콜 또는 이의 유도체를 유효성분으로 포함하는 염증성 질환의 예방 또는 치료용 약학적 조성물
|
|
WO2025196738A1
(en)
*
|
2024-03-22 |
2025-09-25 |
Nanoprime Labs Corp |
Peg- and lecithin-free self-assembling microemulsions carrying cannabinoids and methods for use thereof
|
|
WO2025229641A1
(en)
|
2024-04-29 |
2025-11-06 |
Ananda Scientific, Inc. |
Methods for reducing nicotine and marijuana dependency by administration of cannabinoids
|
|
WO2026083417A1
(en)
|
2024-10-15 |
2026-04-23 |
Lyotropic Delivery Systems Ltd. |
Highly-loaded cannabinoid formulations
|